- Association of Delayed Denosumab Dosing with Increased Risk of Fractures: A Population-Based Retrospective Study
-
Kim KM, Jang SA, Hong NK, Kim CS, Rhee Y, Park SW, Cummings SR, Seo GH
- KMID: 2562722
- Endocrinol Metab.
- 2024 Dec;39(6):946-955.
- doi: 10.3803/EnM.2024.2047
Background: Inhibitory effects of denosumab on bone remodeling are reversible and disappear once treatment is discontinued. Herein, we examined whether and to what extent delayed denosumab administration is also associated... -
- CITED
-
- Close
- SHARE
-
- Close
